Talk:Dulaglutide
| This is the talk page for discussing improvements to the Dulaglutide article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Dulaglutide.
|
Great start for the article, thanks
edit…to the editors involved. The temptation now will be to add updates based on primary sources. If this can be avoided, the article is en route to be a GA. Cheers, and thanks again to those involved. Le Prof 50.179.252.14 (talk) 01:01, 11 May 2016 (UTC)
NICE [UK]
editHas NICE changed it's position on Trulicity, leading to only the lower levels being prescribed in England? Gwladys24 (talk) 21:30, 21 March 2022 (UTC)
Trulicity non-availabilty crisis due to misuse and corporate greed
editIs anyone of the more versed Wikipedians interested in adding an topic about the almost non-availability of Trulicity for people with Diabetes type 2 in Germany (since March 2023) and possibily other nations mainly caused by "Influencers" who are promoting it as a lifestyle medication to lose weight and Lilly not being interested in increasing the production as to rake in maximum profits? 2A02:560:5854:2700:50A1:4FB5:23D0:7349 (talk) 17:22, 7 February 2024 (UTC)